Decision letter for "Semaglutide improves health-related quality of life vs placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)"
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
Keyword(s):
2016 ◽
Vol 37
(2)
◽
pp. 183-189
Keyword(s):
Keyword(s):